Cellanome
Cellanome engages in cutting-edge synthetic biology and informatics methods through its multi-omics platform.
Discovery Tools (Healthcare)
📍 Foster City, CA
Founded 2020
Current Valuation
$525M
as of 2024-Q1
PRIVATE
Cellanome engages in cutting-edge synthetic biology and informatics methods through its multi-omics platform.
Company Profile
Last Round
Series B — $150M (Jan 2024)
Fundraising Status
Series B · $150M · 2y 5mo ago
privateTotal raised $216M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series B | $150M | Jan 2024 | — | $525M |
BiotechnologyGeneticsLife Science
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q1. Refreshed quarterly.